Analysts’ Viewpoint
The global pulmonary valve replacement market is driven by rise in prevalence of pulmonary valve disorders, technological advancements in cardiac surgery, and increase in adoption of minimally invasive procedures. Advancement in pulmonary valve replacement procedures is another factor propelling market expansion. Furthermore, rise in healthcare spending and increase in awareness about the benefits of early detection & treatment of pulmonary valve disorders are expected to augment global pulmonary valve replacement market demand in the near future.
Rise in adoption of pulmonary valve replacement procedures in emerging economies is expected to offer lucrative opportunities to market players. Leading players are investing significantly in the development pulmonary valve replacement products in order to increase market revenue and share.
Pulmonary valve replacement, also known as lung valve replacement, is a surgical procedure to replace a damaged or diseased pulmonary valve. The pulmonary valve is one of the four valves in the heart and is responsible for regulating blood flow from the right ventricle to the pulmonary artery, which carries blood to the lungs for oxygenation. Pulmonary valve surgery or replacement is usually done when the pulmonary valve is not functioning properly, leading to symptoms such as shortness of breath, fatigue, chest pain, or fainting. This could occur due to a congenital defect, such as pulmonary valve stenosis or regurgitation, or as a result of other conditions such as endocarditis, rheumatic fever, or pulmonary hypertension.
During the procedure, the surgeon will remove the damaged pulmonary valve and replace it with either a biological valve (taken from a donor or animal tissue) or a mechanical valve (made of durable materials). The type of valve used depends on various factors such as age, overall health, and lifestyle.
Pulmonary valve disorders, such as pulmonary stenosis and pulmonary regurgitation, are becoming more prevalent across the world. Rise in prevalence of these conditions is largely attributed to factors such as increase in survival rates of infants with congenital heart defects, improved diagnostic methods, and surge in awareness about heart health.
According to the American Heart Association, congenital heart defects affect approximately 1 in 100 newborns in the U.S., and pulmonary valve disorders are among the most common types of congenital heart defects. Additionally, pulmonary valve disorders can also develop in adults as a result of age-related degeneration or damage to the valve.
Changes in lifestyle, such as sedentary behavior, poor diet, and tobacco use; and environmental factors such as air pollution are the other factors contributing to the rise in prevalence of pulmonary valve disorders.
Technological advancements have played a significant role in the growth and development of the medical industry, including the pulmonary valve replacement industry. Advances in surgical techniques have led to the development of minimally invasive procedures for pulmonary valve replacement or pulmonary valve repair. These procedures use small incisions and specialized instruments, resulting in less pain, scarring, and shorter recovery times for patients. 3D printing technology has been used to create patient-specific models of the heart and blood vessels, which can aid in planning and performing complex pulmonary valve replacement surgeries.
Transcatheter pulmonary valve replacement (TPVR) is a minimally invasive procedure that uses a catheter to replace a damaged or diseased pulmonary valve. This procedure avoids the need for open-heart surgery, resulting in faster recovery times and fewer complications. Advances in implant materials, such as biocompatible polymers and titanium alloys, have led to the development of more durable and long-lasting pulmonary valve replacement devices.
Robotic surgery allows surgeons to perform pulmonary valve replacement procedures with greater precision and control, resulting in fewer complications and better outcomes for patients.
In terms of valve type, the global pulmonary valve replacement market has been bifurcated into mechanical valve and biological valve. The mechanical valve segment dominated the global market in 2022. Mechanical valves are made of durable materials, such as metal and plastic, and are designed to last a long time. These work by opening and closing in response to changes in blood pressure and flow, which helps to ensure that blood is moving in the correct direction.
Based on application, the global market has been classified into pulmonary valve stenosis, pulmonary atresia, and others. The pulmonary valve stenosis segment held the largest global pulmonary valve replacement market share in 2022. Rise in prevalence of pulmonary valve stenosis is driving the segment. It is a condition in which the pulmonary valve becomes narrowed, resulting in restricted blood flow from the right ventricle to the lungs. The pulmonary valve is responsible for regulating blood flow from the right ventricle of the heart to the lungs. Pulmonary valve replacement is performed to replace a diseased valve.
In terms of end-user, the global pulmonary valve replacement market has been divided into hospitals, ambulatory surgical centers, and others. The hospitals segment accounted for the largest share of the market in 2022. The segment is driven by increase in patient preference for pulmonary valve replacement procedure in hospitals.
North America accounted for major share of the global market in 2021. The market in the region is likely to expand at a high CAGR from 2023 to 2031. Increase in incidence of heart valve diseases is propelling the market in the region. According to the Centers for Disease Control and Prevention (CDC), heart valve diseases account for about 25,000 deaths in the U.S. each year.
Asia Pacific is the fastest growing region for pulmonary heart valve replacement. The region held leading share of the global market in 2022. The market in Asia Pacific is likely to grow at a rapid pace from 2023 to 2031. This is ascribed to increase in incidence of pulmonary valve disorders and surge in geriatric population.
The global pulmonary valve replacement market is fragmented, with the presence of large number of local as well as international players. Expansion of product portfolio and merger & acquisition are the key strategies adopted by the leading players. Prominent players in the global market are Boston Scientific, Edwards Lifesciences, Medtronic, St. Jude Medical, Abbott Laboratories, Cryolife, LivaNova, Inc., and 4C Medical Technologies, Inc.
Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Size in 2022 |
US$ 1.0 Bn |
|
Forecast (Value) in 2031 |
US$ 1.6 Bn |
|
Growth Rate (CAGR) |
4.9% |
|
Forecast Period |
2023–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global industry was valued at US$ 1.0 Bn in 2022.
It is projected to reach more than US$ 1.6 Bn by 2031.
The CAGR is anticipated to be 4.9% from 2023 to 2031.
Rise in prevalence of pulmonary valve disorders and technological advancements are driving the global market.
North America is expected to account for the largest share of the global market during the forecast period.
Boston Scientific, Edwards Lifesciences, Medtronic, St. Jude Medical, Abbott Laboratories, Cryolife, LivaNova, Inc. and 4C Medical Technologies, Inc. are the prominent players in the global pulmonary valve replacement market.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Pulmonary Valve Replacement Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Pulmonary Valve Replacement Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Key Industry Events
5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
5.3. Pricing Analysis of Different Mechanical Valves
5.4. Pulmonary Diseases Prevalence Overview
6. Global Pulmonary Valve Replacement Market Analysis and Forecast, by Valve Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Valve Type, 2017-2031
6.3.1. Mechanical Valve
6.3.2. Biological Valve
6.3.2.1. Donor Valve
6.3.2.2. Tissue Valve
6.4. Market Attractiveness Analysis, by Valve Type
7. Global Pulmonary Valve Replacement Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017-2031
7.3.1. Pulmonary Valve Stenosis
7.3.2. Pulmonary Atresia
7.3.3. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Pulmonary Valve Replacement Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017-2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Pulmonary Valve Replacement Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Pulmonary Valve Replacement Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Valve Type, 2017-2031
10.2.1. Mechanical Valve
10.2.2. Biological Valve
10.2.2.1. Donor Valve
10.2.2.2. Tissue Valve
10.3. Market Value Forecast, by Application, 2017-2031
10.3.1. Pulmonary Valve Stenosis
10.3.2. Pulmonary Atresia
10.3.3. Others
10.4. Market Value Forecast, by End-user, 2017-2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Valve Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Pulmonary Valve Replacement Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Valve Type, 2017-2031
11.2.1. Mechanical Valve
11.2.2. Biological Valve
11.2.2.1. Donor Valve
11.2.2.2. Tissue Valve
11.3. Market Value Forecast, by Application, 2017-2031
11.3.1. Pulmonary Valve Stenosis
11.3.2. Pulmonary Atresia
11.3.3. Others
11.4. Market Value Forecast, by End-user, 2017-2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Valve Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Pulmonary Valve Replacement Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Valve Type, 2017-2031
12.2.1. Mechanical Valve
12.2.2. Biological Valve
12.2.2.1. Donor Valve
12.2.2.2. Tissue Valve
12.3. Market Value Forecast, by Application, 2017-2031
12.3.1. Pulmonary Valve Stenosis
12.3.2. Pulmonary Atresia
12.3.3. Others
12.4. Market Value Forecast, by End-user, 2017-2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Valve Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Pulmonary Valve Replacement Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Valve Type, 2017-2031
13.2.1. Mechanical Valve
13.2.2. Biological Valve
13.2.2.1. Donor Valve
13.2.2.2. Tissue Valve
13.3. Market Value Forecast, by Application, 2017-2031
13.3.1. Pulmonary Valve Stenosis
13.3.2. Pulmonary Atresia
13.3.3. Others
13.4. Market Value Forecast, by End-user, 2017-2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Valve Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Pulmonary Valve Replacement Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Valve Type, 2017-2031
14.2.1. Mechanical Valve
14.2.2. Biological Valve
14.2.2.1. Donor Valve
14.2.2.2. Tissue Valve
14.3. Market Value Forecast, by Application, 2017-2031
14.3.1. Pulmonary Valve Stenosis
14.3.2. Pulmonary Atresia
14.3.3. Others
14.4. Market Value Forecast, by End-user, 2017-2031
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Valve Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2022
15.3. Company Profiles
15.3.1. Boston Scientific
15.3.1.1. Company Overview
15.3.1.2. Valve Type Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. Edwards Lifesciences
15.3.2.1. Company Overview
15.3.2.2. Valve Type Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Strategic Overview
15.3.3. Medtronic
15.3.3.1. Company Overview
15.3.3.2. Valve Type Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Strategic Overview
15.3.4. St. Jude Medical
15.3.4.1. Company Overview
15.3.4.2. Valve Type Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. Abbott
15.3.5.1. Company Overview
15.3.5.2. Valve Type Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Strategic Overview
15.3.6. Cryolife
15.3.6.1. Company Overview
15.3.6.2. Valve Type Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Strategic Overview
15.3.7. LivaNova, Inc.
15.3.7.1. Company Overview
15.3.7.2. Valve Type Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Strategic Overview
15.3.8. 4C Medical Technologies, Inc.
15.3.8.1. Company Overview
15.3.8.2. Valve Type Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
List of Tables
Table 01: Global Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Valve Type, 2017‒2031
Table 02: Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by 2017‒2031, by Application
Table 03: Global Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by End-user, 2017–2031
Table 04: Global Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Region, 2017–2031
Table 05: North America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Country, 2017–2031
Table 06: North America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Valve Type, 2017‒2031
Table 07: North America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Application, 2017‒2031
Table 08: North America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by End-user, 2017–2031
Table 09: Europe Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Valve Type, 2017‒2031
Table 11: Europe Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Application, 2017‒2031
Table 12: Europe Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Valve Type, 2017‒2031
Table 15: Asia Pacific Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Application, 2017‒2031
Table 16: Asia Pacific Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by End-user, 2017–2031
Table 17: Latin America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 18: Latin America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Valve Type, 2017‒2031
Table 19: Latin America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Application, 2017‒2031
Table 20: Latin America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Middle East & Africa Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Valve Type, 2017‒2031
Table 23: Middle East & Africa Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Application, 2017‒2031
Table 24: Middle East & Africa Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, 2017–2031
Figure 02: Global Pulmonary Valve Replacement Market Value Share, by Valve Type, 2022
Figure 03: Global Pulmonary Valve Replacement Market Value Share, by Application, 2021
Figure 04: Global Pulmonary Valve Replacement Market Value Share, by End-user, 2021
Figure 05: Global Pulmonary Valve Replacement Market Value Share Analysis, by Valve Type, 2022 and 2031
Figure 06: Global Pulmonary Valve Replacement Market Attractiveness Analysis, by Valve Type, 2023-2031
Figure 09: Global Pulmonary Valve Replacement Market Value Share Analysis, by Application, 2022 and 2031
Figure 10: Global Pulmonary Valve Replacement Market Attractiveness Analysis, by Application, 2023-2031
Figure 11: Global Pulmonary Valve Replacement Market Value Share Analysis, by End-user, 2022 and 2031
Figure 12: Global Pulmonary Valve Replacement Market Attractiveness Analysis, by End-user, 2023-2031
Figure 13: Global Pulmonary Valve Replacement Market Value Share Analysis, by Region, 2022 and 2031
Figure 14: Global Pulmonary Valve Replacement Market Attractiveness Analysis, by Region, 2023-2031
Figure 15: North America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, 2017–2031
Figure 16: North America Pulmonary Valve Replacement Market Value Share Analysis, by Country, 2022 and 2031
Figure 17: North America Pulmonary Valve Replacement Market Attractiveness Analysis, by Country, 2023-2031
Figure 18: North America Pulmonary Valve Replacement Market Value Share Analysis, by Valve Type, 2022 and 2031
Figure 19: North America Pulmonary Valve Replacement Market Attractiveness Analysis, by Valve Type, 2023-2031
Figure 20: North America Pulmonary Valve Replacement Market Value Share Analysis, by Application, 2022 and 2031
Figure 21: North America Pulmonary Valve Replacement Market Attractiveness Analysis, by Application, 2023-2031
Figure 22: North America Pulmonary Valve Replacement Market Value Share Analysis, by End-user, 2022 and 2031
Figure 23: North America Pulmonary Valve Replacement Market Attractiveness Analysis, by End-user, 2023-2031
Figure 24: Europe Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, 2017–2031
Figure 25: Europe Pulmonary Valve Replacement Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 26: Europe Pulmonary Valve Replacement Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 27: Europe Pulmonary Valve Replacement Market Value Share Analysis, by Valve Type, 2022 and 2031
Figure 28: Europe Pulmonary Valve Replacement Market Attractiveness Analysis, by Valve Type, 2023-2031
Figure 29: Europe Pulmonary Valve Replacement Market Value Share Analysis, by Application, 2022 and 2031
Figure 30: Europe Pulmonary Valve Replacement Market Attractiveness Analysis, by Application, 2023-2031
Figure 31: Europe Pulmonary Valve Replacement Market Value Share Analysis, by End-user, 2022 and 2031
Figure 32: Europe Pulmonary Valve Replacement Market Attractiveness Analysis, by End-user, 2023-2031
Figure 33: Asia Pacific Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, 2017–2031
Figure 34: Asia Pacific Pulmonary Valve Replacement Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 35: Asia Pacific Pulmonary Valve Replacement Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 36: Asia Pacific Pulmonary Valve Replacement Market Value Share Analysis, by Valve Type, 2022 and 2031
Figure 37: Asia Pacific Pulmonary Valve Replacement Market Attractiveness Analysis, by Valve Type, 2023-2031
Figure 38: Asia Pacific Pulmonary Valve Replacement Market Value Share Analysis, by Application, 2022 and 2031
Figure 39: Asia Pacific Pulmonary Valve Replacement Market Attractiveness Analysis, by Application, 2023-2031
Figure 40: Asia Pacific Pulmonary Valve Replacement Market Value Share Analysis, by End-user, 2022 and 2031
Figure 41: Asia Pacific Pulmonary Valve Replacement Market Attractiveness Analysis, by End-user, 2023-2031
Figure 42: Latin America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, 2017–2031
Figure 43: Latin America Pulmonary Valve Replacement Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 44: Latin America Pulmonary Valve Replacement Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 45: Latin America Pulmonary Valve Replacement Market Value Share Analysis, by Valve Type, 2022 and 2031
Figure 46: Latin America Pulmonary Valve Replacement Market Attractiveness Analysis, by Valve Type, 2023-2031
Figure 47: Latin America Pulmonary Valve Replacement Market Value Share Analysis, by Application, 2022 and 2031
Figure 48: Latin America Pulmonary Valve Replacement Market Attractiveness Analysis, by Application, 2023-2031
Figure 49: Latin America Pulmonary Valve Replacement Market Value Share Analysis, by End-user, 2022 and 2031
Figure 50: Latin America Pulmonary Valve Replacement Market Attractiveness Analysis, by End-user, 2023-2031
Figure 51: Middle East & Africa Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, 2017–2031
Figure 52: Middle East & Africa Pulmonary Valve Replacement Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 53: Middle East & Africa Pulmonary Valve Replacement Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 54: Middle East & Africa Pulmonary Valve Replacement Market Value Share Analysis, by Valve Type, 2022 and 2031
Figure 55: Middle East & Africa Pulmonary Valve Replacement Market Attractiveness Analysis, by Valve Type, 2023-2031
Figure 56: Middle East & Africa Pulmonary Valve Replacement Market Value Share Analysis, by Application, 2022 and 2031
Figure 57: Middle East & Africa Pulmonary Valve Replacement Market Attractiveness Analysis, by Application, 2023-2031
Figure 58: Middle East & Africa Pulmonary Valve Replacement Market Value Share Analysis, by End-user, 2022 and 2031
Figure 59: Middle East & Africa Pulmonary Valve Replacement Market Attractiveness Analysis, by End-user, 2023-2031
Figure 60: Company Share Analysis, 2022
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Pulmonary Valve Replacement Market
